Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO study.

Saved in:
Bibliographic Details
Title: Achieving SVR is associated with long term reduced hazardous alcohol use for people who inject drugs receiving HCV treatment: The HERO study.
Authors: Waters E; University of South Carolina School of Medicine Greenville, Greenville, SC, United States., Obeysekare J; University of South Carolina School of Medicine Greenville, Greenville, SC, United States; Department of Psychiatry, Prisma Health, Greenville, SC, United States; School of Health Research, Clemson University, Clemson, SC, United States., Lopes S; Department of Public Health Sciences, Clemson University, Clemson, SC, United States., Pericot-Valverde I; Department of Psychology, Clemson University College of Behavioral, Social and Health Sciences, Clemson, SC, United States., Norton BL; Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, United States., Tsui JI; Department of Medicine, University of Washington, Seattle, WA, United States., Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, RI, United States., Lum PJ; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Feinberg J; Department of Behavioral Medicine and Psychiatry, and Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, Morgantown, WV, United States., Kim AY; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States., Page K; Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM, United States., Anderson J; Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM, United States., Murray-Krezan C; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Heo M; Department of Public Health Sciences, Clemson University, Clemson, SC, United States., Litwin AH; University of South Carolina School of Medicine Greenville, Greenville, SC, United States; School of Health Research, Clemson University, Clemson, SC, United States; Department of Medicine, Prisma Health, Greenville, SC, United States. Electronic address: alain.litwin@prismahealth.org.
Corporate Authors: HERO Study Group
Source: Drug and alcohol dependence [Drug Alcohol Depend] 2026 Apr 01; Vol. 281, pp. 113081. Date of Electronic Publication: 2026 Feb 10.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Pragmatic Clinical Trial
Journal Info: Publisher: Elsevier Country of Publication: Ireland NLM ID: 7513587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0046 (Electronic) Linking ISSN: 03768716 NLM ISO Abbreviation: Drug Alcohol Depend Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0046
DOI:10.1016/j.drugalcdep.2026.113081